Metropolitan Life Insurance Company (MetLife)’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
CB
Metropolitan Life Insurance Company (MetLife)'s SYNH Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 19,125 shares — an estimated $1.96M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in SYNH in Q3 2015 and held it in 16 quarters. The position peaked at $2.12M in Q4 2019. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 19,125 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $1.96M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 16 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Syneos Health, Inc. Class A Common Stock position peaked at $2.12M in Q4 2019.
- 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.